-
Intravenous lanadelumab for the treatment of moderately ill COVID-19 patients
Engel, J. J., van Linge, C., Wiersinga, W. J., Kouijzer, I. J. E., de Mast, Q., Hassing, R.-J., Huijbens, D. J. H., Leavis, H. L., Schutgens, R., Maas, C., Roes, K. C. B., van de Veerdonk, F. L. & Brüggemann, R., 2026, (E-pub ahead of print) In: British Journal of Clinical Pharmacology.Research output: Contribution to journal › Article › Academic › peer-review
-
Effect of the gut microbiota-derived tryptophan metabolite indole-3-acetic acid in pneumonia
Kullberg, R. F. J., van Linge, C. C. A., Haak, B. W., Paul, P. S., Butler, J. M., Wolff, N., van Engelen, T. S. R., Sikkens, J. J., Bomers, M. K., Lefèvre, A., Cremer, O. L., Roelofs, J. J. T. H., Sovran, B., van den Wijngaard, R., de Vos, A. F., de Jonge, W. J., van der Poll, T. & Wiersinga, W. J., Dec 2025, In: Nature communications. 16, 1, p. 8565 8565.Research output: Contribution to journal › Article › Academic › peer-review
-
Differential platelet protein release profiles in community-acquired pneumonia and COVID-19
Chouchane, O., léopold, V., Michels, E. H. A., de Brabander, J., van Linge, C. C. A., Klarenbeek, A. M., Joost Wiersinga, W., Veer, C. V. ‘. & van der Poll, T., 1 May 2025, In: ERJ Open Research. 11, 3, 00863-2024.Research output: Contribution to journal › Article › Academic › peer-review
- All publications
